Abstract
AbstractWe investigate the information benefits from R&D capitalization by focusing on the role of financial analysts in mitigating information asymmetry. Using a large sample of Korean firms, we find a positive association between analyst coverage and the market valuation of expensed R&D indicating that an analyst's activities can help investors to understand the implications of R&D investments. In contrast, analyst coverage does not significantly improve the valuation of capitalized R&D, suggesting that capitalization itself mitigates information asymmetry between firms and investors. We also find that our results are relevant only for firms with fewer alternative sources of information and firms unaffiliated with business groups.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
